Cognex Corporation

(NASDAQ Global Select)
Back to all articles
Bullish +65

Cognex Corporation (NASDAQ: CGNX): Corporate Profile & Financials

Acquisition Company update AI-generated analysis

πŸ“ˆ Cognex reported fiscal year 2025 revenue of $994.36 million, a 9% year-over-year increase driven by logistics and consumer electronics markets.

πŸ’° Net income reached $114.44 million ($0.68 per diluted share), with operating income margin expanding to 16% of revenue.

🏭 The company completed the acquisition of Moritex Corporation in October 2023 for an enterprise value of approximately $270 million to strengthen optical component capabilities.

πŸ“‰ Gross margins decreased to 67% from 68% due to a $13 million charge for excess and obsolete inventory in Q4 2025.

πŸ’Έ Operating expenses declined by 2% year-over-year due to cost management initiatives and headcount reductions.

🌍 International sales accounted for approximately 67% of total revenue, with significant operations in Europe, Asia, and China.

πŸ›οΈ The company maintains a debt-free balance sheet with substantial cash reserves and available-for-sale debt securities.

βš–οΈ The effective tax rate increased to 37.4% due to a $33 million discrete tax expense from new US legislation (OBBBA).

πŸ€– Cognex is advancing its AI ecosystem through platforms like OneVision to capture long-term automation demand.

🏒 The company sold a 19,000 square-foot building adjacent to headquarters in December 2025 for approximately $7 million.

Bullish Signals
  • Revenue grew 9% year-over-year to $994.36 million, driven by strong performance in logistics and consumer electronics end markets.
  • Operating income margin expanded to 16% of revenue from 13% in the prior year, reflecting improved profitability.
  • The company maintains a fortress balance sheet with zero debt and significant cash reserves for strategic investments.
  • Completed the acquisition of Moritex Corporation for $270 million to expand high-end lens manufacturing and global presence.
  • Operating expenses decreased 2% year-over-year due to successful cost management and headcount optimization efforts.
  • Generated a one-time $13 million revenue boost from a strategic channel partnership in the medical lab automation industry.
Risk Factors
  • Gross margins declined to 67% from 68% due to a $13 million charge for excess and obsolete inventory in Q4 2025.
  • The effective tax rate rose to 37.4% due to a $33 million discrete tax expense accrued under new US legislation (OBBBA).
  • Faces competitive pressure from open-source platforms and advanced AI algorithms that may lower market entry barriers.
Full Analysis
Cognex Corporation (NASDAQ: CGNX) reported fiscal year 2025 revenue of $994.36 million, representing a 9% increase from the prior year. This growth was primarily driven by higher demand in the logistics and consumer electronics sectors, alongside a one-time $13 million revenue recognition related to a strategic channel partnership in medical lab automation. The company achieved an operating income margin of 16% in 2025, up from 13% in 2024, resulting in net income of $114.44 million or $0.68 per diluted share. Gross margins were 67%, slightly down from 68% due to a $13 million charge for excess and obsolete inventory recorded in the fourth quarter following a strategic product portfolio review. Cognex maintains a strong balance sheet with zero debt and significant cash reserves, supported by proprietary machine vision technology and AI capabilities. The company executed a major acquisition of Moritex Corporation in October 2023 for approximately $270 million to expand its optical component capabilities and global manufacturing footprint in China, Vietnam, and Japan. Strategic initiatives include advancing salesforce transformation, expanding the OneVision AI ecosystem, and optimizing operating costs through headcount reductions. However, the effective tax rate rose to 37% due to a $33 million discrete tax expense associated with new United States legislation known as the One Big Beautiful Bill Act.